Life SciencesLiability
Get a quote

TL;DR

Greater Boston runs a deep medical device and medtech cluster alongside its world-leading biotech scene, spanning cardiovascular and interventional devices, imaging, surgical instruments, and increasingly connected, software-driven products. Insuring these manufacturers means sizing products liability towers to device class, tying clinical trial coverage to the region's academic medical centers, and meeting the additional-insured demands of hospital and GPO supply contracts. Connected and software-enabled devices add a cyber and Tech E&O layer, sharpened by Massachusetts data-privacy law.

Boston medical device

Medical Device Insurance for Greater Boston Manufacturers

Greater Boston is best known for biotech, but the same corridor supports one of the country's most concentrated medical device and medtech ecosystems. The region is strong in cardiovascular and interventional devices, diagnostic imaging, surgical instruments, and a fast-growing tier of connected, software-driven products, with Boston Scientific headquartered in Marlborough, Massachusetts. That mix of high-acuity therapeutic devices and academic-medical-center collaboration creates a liability profile distinct from the area's drug developers and cell-and-gene-therapy programs.

For a device manufacturer, the insurance program has to track the specific device class it makes, the clinical evidence it generates, and the contracts it signs to reach hospitals. A Class II interventional catheter carries a very different exposure than a Class I general-use instrument, and a connected monitor that streams patient data brings risks a purely mechanical device never faces. The right structure aligns products liability, clinical trial coverage, contractual insurance requirements, and cyber into a single defensible tower.

Get a quoteRun the Free Analyzer

Last updated 2026-07-13

Cluster shape

The Greater Boston device cluster

Greater Boston pairs its world-leading biotech base with a mature medical device and medtech industry, anchored in cardiovascular and interventional devices, imaging, and surgical instrumentation. Boston Scientific, headquartered in Marlborough, is one of the region's signature device employers, and the surrounding ecosystem of suppliers, contract manufacturers, and early-stage device startups feeds off the same engineering and clinical talent pool.

The area's academic medical centers are central to how devices here are developed and evaluated. Investigator relationships and hospital-based clinical trials give Boston device firms early access to real-world use, but they also concentrate exposure around specific institutions and study protocols. That proximity to leading clinicians is a competitive advantage that has to be matched by clinical trial and products liability coverage.

Increasingly, the cluster is defined by connected and software-driven devices, where firmware, algorithms, and data handling sit alongside physical hardware. This convergence of device engineering and software is distinct from Boston's biotech and cell-and-gene-therapy clusters, which carry their own dedicated coverage architecture. Device manufacturers need a program built for hardware liability, not one designed for a drug or therapy developer.

Coverage architecture

How device coverage is structured

The foundation is products liability sized to device class. Class I general-use devices sit at the lower end of the tower, while Class II and Class III cardiovascular and interventional devices, which can fail inside the body, warrant materially higher limits, with market-typical program towers ranging from roughly $5M to $25M or more depending on device risk, procedure volume, and claims history. Product recall is structured as a separate first-party trigger, funding the direct costs of a field action distinct from third-party bodily-injury liability.

Clinical trial coverage tracks the device's investigational path. For products studied under an Investigational Device Exemption at Boston academic medical centers, the program has to respond to trial-related injury and align with institutional and protocol requirements. This coverage is coordinated with the products tower so that a device moving from IDE study into commercial distribution carries continuous protection rather than a gap at launch.

Contractual risk transfer is where many device programs are tested. Hospital purchase contracts and GPO supplier agreements with organizations such as Vizient, Premier, and HealthTrust routinely require additional-insured status covering both products AND completed operations, on a primary and non-contributory basis, at specified limits. A common and dangerous gap is a blanket additional-insured endorsement that silently excludes products and completed operations, leaving the exact exposure the hospital demanded be covered uninsured. These endorsements have to be read against the underlying supply agreements before signing.

Regulatory + market context

Massachusetts regulatory considerations

Device classification under the FDA framework drives both regulatory obligation and insurance structure, with Class I, II, and III devices facing escalating premarket and post-market requirements that map directly to how a products tower is sized. Clinical work conducted under an Investigational Device Exemption at the region's academic medical centers adds institutional and protocol-level insurance conditions that a Boston manufacturer's program has to satisfy.

For connected and software-driven devices, Massachusetts data-privacy law adds a distinct layer. M.G.L. c. 93H and the state's data-security regulations at 201 CMR 17.00 govern the handling of personal information, so a device that collects or transmits patient data needs cyber and Tech E&O coverage that responds to a data event as well as the underlying software-as-a-medical-device product risk. Here the Tech E&O and cyber tower functions as a primary product-liability vehicle for the software component, not merely a supplement.

Frequently asked

Common questions from Boston medical device operators

What makes Boston medical device insurance different from insuring a biotech?

Greater Boston supports a substantial medtech and medical device industry alongside its biotech scene, and the two carry different exposures. A device manufacturer's risk centers on hardware that can fail in use, products liability sized to device class, recall, and contractual obligations to hospitals, rather than on drug development or clinical pharmacology. The region's academic medical centers also shape device programs through investigator relationships and hospital-based clinical trials, which concentrate exposure differently than a drug study does.

How is the products liability tower sized for cardiovascular and interventional devices?

Products towers are sized to device class and failure severity. Class I general-use devices sit lower in the structure, while Class II and Class III cardiovascular and interventional devices, which can cause serious harm if they fail inside a patient, carry higher limits, with market-typical program towers commonly ranging from roughly $5M to $25M or more depending on procedure volume, device risk, and claims experience. Product recall is placed as a separate first-party coverage so a field action does not erode the third-party liability limits.

What additional-insured requirements do GPOs and hospitals impose on device suppliers?

Hospital purchase contracts and GPO supplier agreements with groups such as Vizient, Premier, and HealthTrust typically require the manufacturer to name the buyer as an additional insured for both products AND completed operations, on a primary and non-contributory basis, at specified limits. The frequent pitfall is a blanket additional-insured endorsement that excludes products and completed operations, which leaves the precise exposure the contract was meant to transfer uninsured. Endorsements should be matched against each supply agreement before it is signed.

How are connected and software-driven devices covered?

Software-as-a-medical-device and connected products need cyber and Tech E&O coverage functioning as a primary product-liability vehicle for the software component, layered with the traditional products tower that covers the physical hardware. Because these devices collect and transmit patient data, Massachusetts data-privacy law under M.G.L. c. 93H and the security regulations at 201 CMR 17.00 adds a data-handling obligation that the cyber layer has to address. The result is an integrated program covering hardware failure, software error, and data events together.

Medical device insurance practice →Device products liability →Boston biotech insurance →Massachusetts state guide →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Boston medical device operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.